Cargando…
Cancer Immunotherapy and Personalized Medicine: Emerging Technologies and Biomarker-Based Approaches
PURPOSE OF REVIEW: The vision and strategy for the 21st century treatment of cancer calls for a personalized approach in which therapy selection is designed for each individual patient. While genomics has led the field of personalized cancer medicine over the past several decades by connecting patie...
Autores principales: | Maciejko, Laura, Smalley, Munisha, Goldman, Aaron |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743227/ https://www.ncbi.nlm.nih.gov/pubmed/29285416 http://dx.doi.org/10.4172/2155-9929.1000350 |
Ejemplares similares
-
Novel technologies and emerging biomarkers for personalized cancer immunotherapy
por: Yuan, Jianda, et al.
Publicado: (2016) -
Systems biology informed neural networks (SBINN) predict response and novel combinations for PD-1 checkpoint blockade
por: Przedborski, Michelle, et al.
Publicado: (2021) -
Preclinical Cancer Models and Biomarkers for Drug Development: New Technologies and Emerging Tools
por: Dhandapani, Muthu, et al.
Publicado: (2017) -
Ovarian Cancer Immunotherapy and Personalized Medicine
por: Morand, Susan, et al.
Publicado: (2021) -
Emerging Biomarkers in the Era of Personalized Cancer Medicine
por: Ricciuti, Biagio, et al.
Publicado: (2019)